Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Michael Untch
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Procedures
Chemicals & Drugs
Concepts & Ideas
Anatomy
Sign-in to see full Profile
Network (preview)
24
Konecny, Gottfried
20
Hepp, Hermann
20
Kahlert, Steffen
16
Bauerfeind, Ingo
13
Sevin, BU
11
Averette, Hervy
10
Angioli, Roberto
10
Sittek, Harald
10
Thomssen, Christoph
9
Pegram, Mark
9
Ditsch, Nina
8
Kessler, M
8
Reiser, Maximilian
8
Slamon, Dennis
7
Schmutzler, Rita
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Michael Untch (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Aapro Matti; Barnadas Agustí; Leonard Robert C; Marangolo Maurizio; Untch Michael; Ukarma Lidia; Burger Hans-Ulrich; Scherhag Armin; Osterwalder Bruno
What is the impact of antithrombotic therapy and risk factors on the frequency of thrombovascular events in patients with metastatic breast cancer receiving epoetin beta?
European journal of cancer (Oxford, England : 1990) 2009;45(17):2984-91.
-
2009: Untch Michael; Möbus Volker; Kuhn Walther; Muck Bernd Rudolph; Thomssen Christoph; Bauerfeind Ingo; Harbeck Nadia; Werner Christoph; Lebeau Annette; Schneeweiss Andreas; Kahlert Stephen; von Koch Franz; Petry Karl Ulrich; Wallwiener Diethelm; Kreienberg Rolf; Albert Ute-Susann; Lück Hans-Joachim; Hinke Axel; Jänicke Fritz; Konecny Gottfried E
Intensive dose-dense compared with conventionally scheduled preoperative chemotherapy for high-risk primary breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(18):2938-45.
-
2009: Bohlius Julia; Schmidlin Kurt; Brillant Corinne; Schwarzer Guido; Trelle Sven; Seidenfeld Jerome; Zwahlen Marcel; Clarke Michael; Weingart Olaf; Kluge Sabine; Piper Margaret; Rades Dirk; Steensma David P; Djulbegovic Benjamin; Fey Martin F; Ray-Coquard Isabelle; Machtay Mitchell; Moebus Volker; Thomas Gillian; Untch Michael; Schumacher Martin; Egger Matthias; Engert Andreas
Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials.
Lancet 2009;373(9674):1532-42.
-
2009: Vodermaier A; Caspari C; Koehm J; Kahlert S; Ditsch N; Untch M
Contextual factors in shared decision making: a randomised controlled trial in women with a strong suspicion of breast cancer.
British journal of cancer 2009;100(4):590-7.
-
2009: Schwarz-Dose Jörg; Untch Michael; Tiling Reinhold; Sassen Stefanie; Mahner Sven; Kahlert Steffen; Harbeck Nadia; Lebeau Annette; Brenner Winfried; Schwaiger Markus; Jaenicke Fritz; Avril Norbert
Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucose.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(4):535-41.
-
2009: Schwartz Gordon F; Hughes Kevin S; Lynch Henry T; Fabian Carol J; Fentiman Ian S; Robson Mark E; Domchek Susan M; Hartmann Lynn C; Holland Roland; Winchester David J; Anderson Benjamin O; Arun Banu K; Bartelink Harry; Bernard Philip; Bonanni Bernardo; Cady Blake; Clough Krishna B; Feig Stephen A; Heywang-Köbrunner Sylvia H; Howell Anthony; Isaacs Claudine; Kopans Daniel B; Mansel Robert E; Masood Shahla; Palazzo Juan P; Pressman Peter I; Solin Lawrence J; Untch Michael
Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007.
The breast journal 2009;15(1):4-16.
-
2009: Bohlius Julia; Schmidlin Kurt; Brillant Corinne; Schwarzer Guido; Trelle Sven; Seidenfeld Jerome; Zwahlen Marcel; Clarke Mike J; Weingart Olaf; Kluge Sabine; Piper Margaret; Napoli Maryann; Rades Dirk; Steensma David; Djulbegovic Benjamin; Fey Martin F; Ray-Coquard Isabelle; Moebus Volker; Thomas Gillian; Untch Michael; Schumacher Martin; Egger Matthias; Engert Andreas
Erythropoietin or Darbepoetin for patients with cancer--meta-analysis based on individual patient data.
Cochrane database of systematic reviews (Online) 2009;(3):CD007303.
-
2009: Untch Michael; von Minckwitz Gunter
Recent advances in systemic therapy: advances in neoadjuvant (primary) systemic therapy with cytotoxic agents.
Breast cancer research : BCR 2009;11(2):203.
-
2008: Untch Michael; Jackisch Christian
Exemestane in early breast cancer: a review.
Therapeutics and clinical risk management 2008;4(6):1295-304.
-
2008: Hermelink Kerstin; Henschel Volkmar; Untch Michael; Bauerfeind Ingo; Lux Michael Patrick; Munzel Karin
Short-term effects of treatment-induced hormonal changes on cognitive function in breast cancer patients: results of a multicenter, prospective, longitudinal study.
Cancer 2008;113(9):2431-9.
-
2008: Lenhard Miriam S; Bauerfeind Ingo; Untch Michael
Breast cancer and pregnancy: challenges of chemotherapy.
Critical reviews in oncology/hematology 2008;67(3):196-203.
-
2008: Untch M; Gelber R D; Jackisch C; Procter M; Baselga J; Bell R; Cameron D; Bari M; Smith I; Leyland-Jones B; de Azambuja E; Wermuth P; Khasanov R; Feng-Yi F; Constantin C; Mayordomo J I; Su C-H; Yu S-Y; Lluch A; Senkus-Konefka E; Price C; Haslbauer F; Suarez Sahui T; Srimuninnimit V; Colleoni M; Coates A S; Piccart-Gebhart M J; Goldhirsch A;
Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(6):1090-6.
-
2008: Lenhard Miriam S; Kahlert Steffen; Himsl Isabelle; Ditsch Nina; Untch Michael; Bauerfeind Ingo
Phyllodes tumour of the breast: clinical follow-up of 33 cases of this rare disease.
European journal of obstetrics, gynecology, and reproductive biology 2008;138(2):217-21.
-
2008: Aapro Matti; Leonard Robert C; Barnadas Agustí; Marangolo Maurizio; Untch Michael; Malamos Nikolaos; Mayordomo José; Reichert Dietmar; Pedrini José Luiz; Ukarma Lidia; Scherhag Armin; Burger Hans-Ulrich
Effect of once-weekly epoetin beta on survival in patients with metastatic breast cancer receiving anthracycline- and/or taxane-based chemotherapy: results of the Breast Cancer-Anemia and the Value of Erythropoietin (BRAVE) study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(4):592-8.
-
2007: Kaufmann M; von Minckwitz G; Bear H D; Buzdar A; McGale P; Bonnefoi H; Colleoni M; Denkert C; Eiermann W; Jackesz R; Makris A; Miller W; Pierga J-Y; Semiglazov V; Schneeweiss A; Souchon R; Stearns V; Untch M; Loibl S
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(12):1927-34.
-
2007: Laessig Dorit; Nagel Dorothea; Heinemann Volker; Untch Michael; Kahlert Steffen; Bauerfeind Ingo; Stieber Petra
Importance of CEA and CA 15-3 during disease progression in metastatic breast cancer patients.
Anticancer research 2007;27(4A):1963-8.
-
2007: Bauerfeind Ingo G; Kahlert Steffen; Himsl Isabelle; Sorokina Yevgenia; Ruehl Ina M; Lebeau Annette; Linke Reiner; Untch Michael; Friese Klaus
The risk of non-sentinel metastases in primary breast cancer.
Anticancer research 2007;27(4A):1929-32.
-
2007: Schmid Peter; Untch Michael; Kossé Valentin; Bondar Grigorij; Vassiljev Leonid; Tarutinov Valerie; Lehmann Ute; Maubach Lutz; Meurer Juergen; Wallwiener Diethelm; Possinger Kurt
Leuprorelin acetate every-3-months depot versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant treatment in premenopausal patients with node-positive breast cancer: the TABLE study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(18):2509-15.
-
2007: Hermelink Kerstin; Untch Michael; Lux Michael P; Kreienberg Rolf; Beck Thomas; Bauerfeind Ingo; Münzel Karin
Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study.
Cancer 2007;109(9):1905-13.
-
2007: Hunz M; Jetter A; Warm M; Pantke E; Tuscher M; Hempel G; Jaehde U; Untch M; Kurbacher C; Fuhr U
Plasma and tissue pharmacokinetics of epirubicin and Paclitaxel in patients receiving neoadjuvant chemotherapy for locally advanced primary breast cancer.
Clinical pharmacology and therapeutics 2007;81(5):659-68.
-
2007: Untch Michael; Jackisch Christian
Optimal treatment strategies in hormone-responsive early breast cancer: the role of aromatase inhibitors.
Onkologie 2007;30(1-2):55-64.
-
2007: Smith Ian; Procter Marion; Gelber Richard D; Guillaume Sébastien; Feyereislova Andrea; Dowsett Mitch; Goldhirsch Aron; Untch Michael; Mariani Gabriella; Baselga Jose; Kaufmann Manfred; Cameron David; Bell Richard; Bergh Jonas; Coleman Robert; Wardley Andrew; Harbeck Nadia; Lopez Roberto I; Mallmann Peter; Gelmon Karen; Wilcken Nicholas; Wist Erik; Sánchez Rovira Pedro; Piccart-Gebhart Martine J;
2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial.
Lancet 2007;369(9555):29-36.
-
2006: Lenhard Miriam S; Johnson Thorsten R C; Himsl Isabelle; Ditsch Nina; Rueckert Sandra; Friese Klaus; Untch Michael
Obstetrical and gynecological writing and publishing in Europe.
European journal of obstetrics, gynecology, and reproductive biology 2006;129(2):119-23.
-
2006: Vodermaier Andrea; Bauerfeind Ingo; Untch Michael; Nestle-Krämling Carolin
[Prophylactic mastectomy in women at high risk for breast and ovarian cancer: qualitative analysis of the decision making process and long-term satisfaction of two women carrying a BRCA1-mutation]
Psychotherapie, Psychosomatik, medizinische Psychologie 2006;56(9-10):351-61.
-
2006: Hakulinen Timo; Untch Michael; Farmer Richard;
What is new in breast cancer? The expanding role of aromatase inhibitors.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2006;22 Suppl 2():1-13.
-
2006: Frank Bernd; Hemminki Kari; Wappenschmidt Barbara; Klaes Rüdiger; Meindl Alfons; Schmutzler Rita K; Bugert Peter; Untch Michael; Bartram Claus R; Burwinkel Barbara
Variable number of tandem repeats polymorphism in the SMYD3 promoter region and the risk of familial breast cancer.
International journal of cancer. Journal international du cancer 2006;118(11):2917-8.
-
2006: Kiewe Philipp; Hasmüller Stephan; Kahlert Steffen; Heinrigs Maja; Rack Brigitte; Marmé Alexander; Korfel Agnieszka; Jäger Michael; Lindhofer Horst; Sommer Harald; Thiel Eckhard; Untch Michael
Phase I trial of the trifunctional anti-HER2 x anti-CD3 antibody ertumaxomab in metastatic breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(10):3085-91.
-
2006: Frank Bernd; Hemminki Kari; Meindl Alfons; Wappenschmidt Barbara; Klaes Rüdiger; Schmutzler Rita K; Untch Michael; Bugert Peter; Bartram Claus R; Burwinkel Barbara
Association of the ARLTS1 Cys148Arg variant with familial breast cancer risk.
International journal of cancer. Journal international du cancer 2006;118(10):2505-8.
-
2006: Kaufmann Manfred; Hortobagyi Gabriel N; Goldhirsch Aron; Scholl Suzy; Makris Andreas; Valagussa Pinuccia; Blohmer Jens-Uwe; Eiermann Wolfgang; Jackesz Raimund; Jonat Walter; Lebeau Annette; Loibl Sibylle; Miller William; Seeber Sigfried; Semiglazov Vladimir; Smith Roy; Souchon Rainer; Stearns Vered; Untch Michael; von Minckwitz Gunter
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(12):1940-9.
-
2006: Vaclavicek Annika; Hemminki Kari; Bartram Claus R; Wagner Kerstin; Wappenschmidt Barbara; Meindl Alfons; Schmutzler Rita K; Klaes Rüdiger; Untch Michael; Burwinkel Barbara; Försti Asta
Association of prolactin and its receptor gene regions with familial breast cancer.
The Journal of clinical endocrinology and metabolism 2006;91(4):1513-9.
-
2006: Lenhard S M; Untch M; Himsl I; Ditsch N; Bittmann I; Friese K; Bauerfeind I
The high-grade endometrial sarcoma: a rare entity.
Archives of gynecology and obstetrics 2006;274(1):56-9.
-
2006: Stemmler H J; Kahlert S; Siekiera W; Untch M; Heinrich B; Heinemann V
Characteristics of patients with brain metastases receiving trastuzumab for HER2 overexpressing metastatic breast cancer.
Breast (Edinburgh, Scotland) 2006;15(2):219-25.
-
2006: Frank Bernd; Hemminki Kari; Wappenschmidt Barbara; Meindl Alfons; Klaes Rüdiger; Schmutzler Rita K; Bugert Peter; Untch Michael; Bartram Claus R; Burwinkel Barbara
Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with the CASP8 D302H variant.
Carcinogenesis 2006;27(3):606-9.
-
2006: Konecny Gottfried E; Pegram Mark D; Venkatesan Natarajan; Finn Richard; Yang Guorong; Rahmeh Martina; Untch Michael; Rusnak David W; Spehar Glenn; Mullin Robert J; Keith Barry R; Gilmer Tona M; Berger Mark; Podratz Karl C; Slamon Dennis J
Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells.
Cancer research 2006;66(3):1630-9.
-
2006: Wilkening Stefan; Bermejo Justo Lorenzo; Burwinkel Barbara; Klaes Rüdiger; Bartram Claus R; Meindl Alfons; Bugert Peter; Schmutzler Rita K; Wappenschmidt Barbara; Untch Michael; Hemminki Kari; Försti Asta
The single nucleotide polymorphism IVS1+309 in mouse double minute 2 does not affect risk of familial breast cancer.
Cancer research 2006;66(2):646-8.
-
2005: Stemmler Hans-Joachim; Kahlert Steffen; Siekiera Wolfgang; Untch Michael; Heinrich Bernhard; Heinemann Volker
Prolonged survival of patients receiving trastuzumab beyond disease progression for HER2 overexpressing metastatic breast cancer (MBC).
Onkologie 2005;28(11):582-6.
-
2005: Frank Bernd; Hemminki Kari; Shanmugam Kalai S; Meindl Alfons; Klaes Rüdiger; Schmutzler Rita K; Wappenschmidt Barbara; Untch Michael; Bugert Peter; Bartram Claus R; Burwinkel Barbara
Association of death receptor 4 haplotype 626C-683C with an increased breast cancer risk.
Carcinogenesis 2005;26(11):1975-7.
-
2005: Stemmler H J; Salat C; Lindhofer H; Menzel H; Untch M; Kahlert S; Konecny G; Sauer H; Ledderose G; Heinemann V; Kolb H J
Combined treatment of metastatic breast cancer (MBC) by high-dose chemotherapy (HDCT) and bispecific antibodies: a pilot study.
Anticancer research 2005;25(4):3047-54.
-
2005: Rueckert S; Ruehl I; Kahlert S; Konecny G; Untch M
A monoclonal antibody as an effective therapeutic agent in breast cancer: trastuzumab.
Expert opinion on biological therapy 2005;5(6):853-66.
-
2005: Leonard R C; Untch M; Von Koch F
Management of anaemia in patients with breast cancer: role of epoetin.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(5):817-24.
-
2005: Sittek H; Wieser A; Kessler M; Britsch S; Vick C; Untch M; Reiser M
[Sonographically guided, minimally invasive biopsy of uncertain mammary lesions. Clinical experience with a new biopsy system]
Der Radiologe 2005;45(3):269-77.
-
2005: Sittek H; Heske N; Kessler M; Britsch S; Vick C; Untch M; Reiser M
[O-twist marker for post-interventional marking in imaging of suspected breast lesions]
Der Radiologe 2005;45(3):223-9.
-
2005: Tiling Reinhold; Kessler Mareike; Untch Michael; Sommer Harald; Linke Rainer; Hahn Klaus
Initial evaluation of breast cancer using Tc-99m sestamibi scintimammography.
European journal of radiology 2005;53(2):206-12.
-
2005: Kuehn Thorsten; Bembenek Andreas; Decker Thomas; Munz Dieter Ludwig; Sautter-Bihl Marie-Luise; Untch Michael; Wallwiener Diethelm;
A concept for the clinical implementation of sentinel lymph node biopsy in patients with breast carcinoma with special regard to quality assurance.
Cancer 2005;103(3):451-61.
-
2004: Untch M; Himsl I; Kahlert S; Lueck H J; Eidtmann H; Du Bois A; Meerpohl H G; Thomssen C; Harbeck N; Jackisch C; Kreienberg R; Emons G; Wallwiener D; Wiese W; Schaller G; Kuhn W; Muscholl M; Pauschinger M; Langer B
Anthracycline and trastuzumab in breast cancer treatment.
Oncology (Williston Park, N.Y.) 2004;18(14 Suppl 14):59-64.
-
2004: Bell Richard; Verma Shail; Untch Michael; Cameron David; Smith Ian
Maximizing clinical benefit with trastuzumab.
Seminars in oncology 2004;31(5 Suppl 10):35-44.
-
2004: Konecny Gottfried E; Thomssen Christoph; Lück Hans Joachim; Untch Michael; Wang He-Jing; Kuhn Walter; Eidtmann Holger; du Bois Andreas; Olbricht Sigrid; Steinfeld Dieter; Möbus Volker; von Minckwitz Gunter; Dandekar Suganda; Ramos Lillian; Pauletti Giovanni; Pegram Mark D; Jänicke Fritz; Slamon Dennis J
Her-2/neu gene amplification and response to paclitaxel in patients with metastatic breast cancer.
Journal of the National Cancer Institute 2004;96(15):1141-51.
-
2004: Kahlert S; Bauerfeind I; Strauss A; Untch M
[Breast cancer treatment during pregnancy - experiences in the department of OB/GYN Grosshadern-Munich and review of international data]
Zentralblatt für Gynäkologie 2004;126(3):159-66.
-
2004: Biganzoli Laura; Untch Michael; Skacel Tomas; Pico José-Luis
Neulasta (pegfilgrastim): a once-per-cycle option for the management of chemotherapy-induced neutropenia.
Seminars in oncology 2004;31(3 Suppl 8):27-34.
-
2004: Dufault Michael R; Betz Beate; Wappenschmidt Barbara; Hofmann Wera; Bandick Katrin; Golla Astrid; Pietschmann Andrea; Nestle-Krämling Caroline; Rhiem Kerstin; Hüttner Christine; von Lindern Celia; Dall Peter; Kiechle Marion; Untch Michael; Jonat Walter; Meindl Alfons; Scherneck Siegfried; Niederacher Dieter; Schmutzler Rita K; Arnold Norbert
Limited relevance of the CHEK2 gene in hereditary breast cancer.
International journal of cancer. Journal international du cancer 2004;110(3):320-5.
-
2004: Kühn T; Bembenek A; Büchels H; Decker T; Dunst J; Müllerleile U; Munz D L; Ostertag H; Sautter-Bihl M L; Schirrmeister H; Tulusan A H; Untch M; Winzer K J; Wittekind C;
[Sentinel node biopsy in breast carcinoma. Interdisciplinary agreement consensus of the German Society for Serology for quality controlled application in routine clinical testing]
Der Pathologe 2004;25(3):238-43; discussion 244.
-
2004: Untch M; Eidtmann H; du Bois A; Meerpohl H G; Thomssen Ch; Ebert A; Harbeck N; Jackisch C; Heilman V; Emons G; Wallwiener D; Wiese W; Blohmer J-U; Höffken K; Kuhn W; Reichardt P; Muscholl M; Pauschinger M; Langer B; Lück H J
Cardiac safety of trastuzumab in combination with epirubicin and cyclophosphamide in women with metastatic breast cancer: results of a phase I trial.
European journal of cancer (Oxford, England : 1990) 2004;40(7):988-97.
-
2004: Kahlert S; von Koch F; Ditsch N; Untch M
[Adjuvant treatment of breast cancer in 2004. A review of the 8th consensus conference of St. Gallen and new study results]
Gynäkologisch-geburtshilfliche Rundschau 2004;44(2):102-12.
-
2004: Rühl I; Bauerfeind I; Kahlert S; Untch M; Hepp H
[Neoadjuvant therapy of breast cancer]
Gynäkologisch-geburtshilfliche Rundschau 2004;44(2):92-101.
-
2004: Bauerfeind Ingo; Himsl Isabelle; Kühn Thorsten; Untch Michael; Hepp Hermann
[Sentinel lymph node biopsy in breast cancer: state of the art]
Gynäkologisch-geburtshilfliche Rundschau 2004;44(2):84-91.
-
2004: Sittek H; Kessler M; Untch M; Reiser M
[Minimally invasive biopsy and preoperative marking of suspect mammary lesions]
Gynäkologisch-geburtshilfliche Rundschau 2004;44(2):69-83.
-
2004: Georges B; Hermelink K; Untch M; Hepp H
[Current debate on hormone replacement therapy]
Gynäkologisch-geburtshilfliche Rundschau 2004;44(2):63-8.
-
2004: Vodermaier Andrea; Caspari Cornelia; Köhm Janna; Bauerfeind Ingo; Kahlert Steffen; Untch Michael
[Shared decision-making in primary breast cancer]
Zeitschrift für ärztliche Fortbildung und Qualitätssicherung 2004;98(2):127-33.
-
2004: Konecny Gottfried E; Meng Y Gloria; Untch Michael; Wang He-Jing; Bauerfeind Ingo; Epstein Melinda; Stieber Petra; Vernes Jean-Michel; Gutierrez Johnny; Hong Kyu; Beryt Malgorzata; Hepp Hermann; Slamon Dennis J; Pegram Mark D
Association between HER-2/neu and vascular endothelial growth factor expression predicts clinical outcome in primary breast cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(5):1706-16.
-
2004: Kühn T; Bembenek A; Büchels H; Decker T; Dunst J; Müllerleile U; Munz D L; Ostertag H; Sautter-Bihl M L; Schirrmeister H; Tulusan A H; Untch M; Winzer K J; Wittekind C;
[Sentinel node biopsy in breast cancer]
Nuklearmedizin. Nuclear medicine 2004;43(1):4-9.
-
2003: Strauss A; Middendorf K; Müller-Egloff S; Heer I M; Untch M; Bauerfeind I
[Sonographically guided percutaneous needle aspiration of breast abscesses - a minimal-invasive alternative to surgical incision]
Ultraschall in der Medizin (Stuttgart, Germany : 1980) 2003;24(6):393-8.
-
2003: Kaufmann Manfred; von Minckwitz Gunter; Smith Roy; Valero Vicente; Gianni Luca; Eiermann Wolfgang; Howell Anthony; Costa Serban Dan; Beuzeboc Philippe; Untch Michael; Blohmer Jens-Uwe; Sinn Hans-Peter; Sittek Rolf; Souchon Rainer; Tulusan Augustinos H; Volm Tanja; Senn Hans-Jörg
International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(13):2600-8.
-
2003: Untch Michael; Ditsch Nina; Hermelink Kerstin
Immunotherapy: new options in breast cancer treatment.
Expert review of anticancer therapy 2003;3(3):403-8.
-
2003: Caspari C; Untch M; Vodermaier A
[Shared decision making in breast cancer patients--qualitative study on mutual decision making in breast cancer in a university hospital]
Gesundheitswesen (Bundesverband der Ärzte des Öffentlichen Gesundheitsdienstes (Germany)) 2003;65(3):190-9.
-
2003: Tiling R; Kessler M; Untch M; Sommer H; Linke R; Brinkbäumer K; Hahn K
Breast cancer: monitoring response to neoadjuvant chemotherapy using Tc-99m sestamibi scintimammography.
Onkologie 2003;26(1):27-31.
-
2003: Konecny Gottfried; Pauletti Giovanni; Pegram Mark; Untch Michael; Dandekar Sugandha; Aguilar Zuleima; Wilson Cindy; Rong Hong-Mei; Bauerfeind Ingo; Felber Margret; Wang He-Jing; Beryt Malgorzata; Seshadri Ram; Hepp Herrmann; Slamon Dennis J
Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer.
Journal of the National Cancer Institute 2003;95(2):142-53.
-
2003: Ditsch Nina; Mayer Barbara; Rolle Michaela; Untch Michael; Schildberg Friedrich Wilhelm; Funke Ilona
Estrogen receptor expression profile of disseminated epithelial tumor cells in bone marrow of breast cancer patients.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2003;162():141-7.
-
2003: Stieber Petra; Molina Rafael; Chan Daniel W; Fritsche Herbert A; Beyrau Ralf; Bonfrer Jean M G; Filella Xavier; Gornet Terrie G; Hoff Torsten; Jäger Wolfram; van Kamp Gerard J; Nagel Dorothea; Peisker Klaus; Sokoll Lori J; Troalen Frédéric; Untch Michael; Domke Ingrid
Clinical evaluation of the Elecsys CA 15-3 test in breast cancer patients.
Clinical laboratory 2003;49(1-2):15-24.
-
2003: Kurbacher Christian M; Grecu Ottilia M; Stier Ursula; Gilster Tobias J; Janát Margit-M; Untch Michael; Konecny Gottfried; Bruckner Howard W; Cree Ian A
ATP chemosensitivity testing in ovarian and breast cancer: early clinical trials.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2003;161():221-30.
-
2003: Untch M; Ditsch N; Langer E; Kurbacher C; Crohns C; Konecny G; Kahlert S; Bauerfeind I; Hepp H
Chemosensitivity testing in gynecologic oncology--dream or reality?
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2003;161():146-58.
-
2002: Ditsch N; Funke I; Mayer B; Untch M
[Detection of disseminated tumor cells in bone marrow--currently of no practical therapeutic value]
MMW Fortschritte der Medizin 2002;144(41):37-9.
-
2002: Schmid Peter; Untch Michael; Wallwiener Diethelm; Kossé Valentin; Bondar Grigorij; Vassiljev Leonid; Tarutinov Valerie; Kienle Erika; Lüftner Diana; Possinger Kurt;
Cyclophosphamide, methotrexate and fluorouracil (CMF) versus hormonal ablation with leuprorelin acetate as adjuvant treatment of node-positive, premenopausal breast cancer patients: preliminary results of the TABLE-study (Takeda Adjuvant Breast cancer study with Leuprorelin Acetate).
Anticancer research 2002;22(4):2325-32.
-
2002: Tiling R; Linke R; Kessler M; Untch M; Sommer H; Brinkbäumer K; Becker I; Hahn K
[Breast scintigraphy using 99mTc-sestamibi--use and limitations]
Nuklearmedizin. Nuclear medicine 2002;41(3):148-56.
-
2002: Ebeling F G; Stieber P; Untch M; Nagel D; Konecny G E; Schmitt U M; Fateh-Moghadam A; Seidel D
Serum CEA and CA 15-3 as prognostic factors in primary breast cancer.
British journal of cancer 2002;86(8):1217-22.
-
2002: Sittek H; Perlet C; Schneider P; Untch M; Kolopenko T; Reiser M
[Stereotactic vacuum biopsy in prone and sitting position]
Der Radiologe 2002;42(1):19-24.
-
2001: Stieber P; Molina R; Chan D W; Fritsche H A; Beyrau R; Bonfrer J M; Filella X; Gornet T G; Hoff T; Jäger W; van Kamp G J; Nagel D; Peisker K; Sokoll L J; Troalen F; Untch M; Domke I
Evaluation of the analytical and clinical performance of the Elecsys CA 15-3 immunoassay.
Clinical chemistry 2001;47(12):2162-4.
-
2001: Konecny G; Fritz M; Untch M; Lebeau A; Felber M; Lude S; Beryt M; Hepp H; Slamon D; Pegram M
HER-2/neu overexpression and in vitro chemosensitivity to CMF and FEC in primary breast cancer.
Breast cancer research and treatment 2001;69(1):53-63.
-
2001: Konecny G; Untch M; Arboleda J; Wilson C; Kahlert S; Boettcher B; Felber M; Beryt M; Lude S; Hepp H; Slamon D; Pegram M
Her-2/neu and urokinase-type plasminogen activator and its inhibitor in breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(8):2448-57.
-
2001: Konecny G; Untch M; Slamon D; Beryt M; Kahlert S; Felber M; Langer E; Lude S; Hepp H; Pegram M
Drug interactions and cytotoxic effects of paclitaxel in combination with carboplatin, epirubicin, gemcitabine or vinorelbine in breast cancer cell lines and tumor samples.
Breast cancer research and treatment 2001;67(3):223-33.
-
2001: Tiling R; Linke R; Untch M; Richter A; Fieber S; Brinkbäumer K; Tatsch K; Hahn K
18F-FDG PET and 99mTc-sestamibi scintimammography for monitoring breast cancer response to neoadjuvant chemotherapy: a comparative study.
European journal of nuclear medicine 2001;28(6):711-20.
-
2001: Konecny G; Untch M; Pihan A; Kimmig R; Gropp M; Stieber P; Hepp H; Slamon D; Pegram M
Association of urokinase-type plasminogen activator and its inhibitor with disease progression and prognosis in ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(6):1743-9.
-
2001: Untch M; Von Koch F; Crohns C; Sobotta K; Kahlert S; Konecny G; Hepp H
Dose-dense and sequential strategies in adjuvant breast cancer therapy.
Oncology (Williston Park, N.Y.) 2001;15(5 Suppl 7):14-20.
-
2001: Lebeau A; Deimling D; Kaltz C; Sendelhofert A; Iff A; Luthardt B; Untch M; Löhrs U
Her-2/neu analysis in archival tissue samples of human breast cancer: comparison of immunohistochemistry and fluorescence in situ hybridization.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(2):354-63.
-
2000: Sittek H; Linsmeier E; Perlet C; Schneider P; Baudrexel C; Untch M; Reiser M
[Preoperative marking and biopsy of nonpalpable breast lesions with a guidance system for the open Magnetom]
Der Radiologe 2000;40(11):1098-105.
-
2000: Untch M; von Koch F; Kahlert S; Konecny G
Overview of epirubicin-based adjuvant therapy in breast cancer.
Clinical breast cancer 2000;1 Suppl 1():S41-5.
-
2000: Konecny G; Crohns C; Pegram M; Felber M; Lude S; Kurbacher C; Cree I A; Hepp H; Untch M
Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer.
Gynecologic oncology 2000;77(2):258-63.
-
2000: Hillemanns P; Untch M; Dannecker C; Baumgartner R; Stepp H; Diebold J; Weingandt H; Pröve F; Korell M
Photodynamic therapy of vulvar intraepithelial neoplasia using 5-aminolevulinic acid.
International journal of cancer. Journal international du cancer 2000;85(5):649-53.
-
2000: Prechtl A; Harbeck N; Thomssen C; Meisner C; Braun M; Untch M; Wieland M; Lisboa B; Cufer T; Graeff H; Selbmann K; Schmitt M; Jänicke F
Tumor-biological factors uPA and PAI-1 as stratification criteria of a multicenter adjuvant chemotherapy trial in node-negative breast cancer.
The International journal of biological markers 2000;15(1):73-8.
-
2000: Konecny G; Frank M; Kahlert S; Untch M; Hepp H
[Retrospective analysis of dose intensity of epirubicin in breast cancer]
Gynäkologisch-geburtshilfliche Rundschau 2000;40(3-4):145-52.
-
1999: Ebeling F C; Schmitt U M; Untch M; Nagel D; Fateh-Moghadam A; Stieber P; Seidel D
Tumour markers CEA and CA 15-3 as Prognostic factors in breast cancer--univariate and multivariate analysis.
Anticancer research 1999;19(4A):2545-50.
-
1999: Hillemanns P; Korell M; Schmitt-Sody M; Baumgartner R; Beyer W; Kimmig R; Untch M; Hepp H
Photodynamic therapy in women with cervical intraepithelial neoplasia using topically applied 5-aminolevulinic acid.
International journal of cancer. Journal international du cancer 1999;81(1):34-8.
-
1999: Hillemanns P; Untch M; Pröve F; Baumgartner R; Hillemanns M; Korell M
Photodynamic therapy of vulvar lichen sclerosus with 5-aminolevulinic acid.
Obstetrics and gynecology 1999;93(1):71-4.
-
1998: Pahernik S A; Botzlar A; Hillemanns P; Dellian M; Kirschstein M; Abels C; Korell M; Mueller-Hoecker J; Untch M; Goetz A E
Pharmacokinetics and selectivity of aminolevulinic acid-induced porphyrin synthesis in patients with cervical intra-epithelial neoplasia.
International journal of cancer. Journal international du cancer 1998;78(3):310-4.
-
1998: Ritzke C; Stieber P; Untch M; Nagel D; Eiermann W; Fateh-Moghadam A
Alkaline phosphatase isoenzymes in detection and follow up of breast cancer metastases.
Anticancer research 1998;18(2B):1243-9.
-
1998: Lück H J; Thomssen C; Du Bois A; Untch M; Lisboa B; Köhler G; Diergarten K
Metastatic breast cancer: experience with the combination paclitaxel plus epirubicin.
Oncology (Williston Park, N.Y.) 1998;12(1 Suppl 1):36-9.
-
1998: Sittek H; Perlet C; Untch M; Kessler M; Reiser M
[Dynamic MR-mammography in invasive lobular breast cancer]
Röntgenpraxis; Zeitschrift für radiologische Technik 1998;51(7):235-42.
-
1997: Lück H J; Thomssen C; du Bois A; Untch M; Lisboa B; Köhler G; Diergarten K
Phase II study of paclitaxel and epirubicin as first-line therapy in patients with metastatic breast cancer.
Seminars in oncology 1997;24(5 Suppl 17):S17-35-S17-39.
-
1997: Sittek H; Perlet C; Herrmann K; Linsmeier E; Kolem H; Untch M; Kessler M; Reiser M
[MR mammography. Preoperative marking of non-palpable breast lesions with the Magnetom open at 0.2 T]
Der Radiologe 1997;37(9):685-91.
-
1997: Sittek H; Kessler M; Heuck A F; Bredl T; Perlet C; Künzer I; Lebeau A; Untch M; Reiser M
[Morphology and contrast enhancement of ductal carcinoma in situ in dynamic 1.0 T MR mammography]
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 1997;167(3):247-51.
-
1997: Lück H J; Du Bois A; Thomssen C; Lisboa B; Untch M; Köhler G; Hecker D
Paclitaxel and epirubicin as first-line therapy for patients with metastatic breast cancer.
Oncology (Williston Park, N.Y.) 1997;11(4 Suppl 3):34-7.
-
1997: Lück H J; Thomssen C; du Bois A; Lisboa B W; Untch M; Kühnle H; Jänicke F; Meerpohl H G; Lindner C; Konecny G; Hecker D; Diergarten K
Preliminary results of a phase II study of epirubicin and paclitaxel as first-line treatment in patients with metastatic breast cancer.
Seminars in oncology 1997;24(1 Suppl 3):S13-6.
-
1997: Konecny G; Untch M; Hepp H
[New drugs in therapy of breast carcinoma: current status and outlook]
Gynäkologisch-geburtshilfliche Rundschau 1997;37(2):54-61.
-
1996: Sittek H; Kessler M; Müller-Lisse U; Untch M; Bohmert H; Reiser M
[Technics for the preoperative marking of nonpalpable breast lesions in MRT]
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 1996;165(1):84-7.
-
1996: Sittek H; Kessler M; Heuck A F; Lebeau A; Kohnert M; Untch M; Bohmert H; Reiser M
[Dynamic MR mammography: is the course of signal intensification suitable for the differentiation of different forms of mastopathy?]
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 1996;165(1):59-63.
-
1996: Funke I; Fries S; Rolle M; Heiss M M; Untch M; Bohmert H; Schildberg F W; Jauch K W
Comparative analyses of bone marrow micrometastases in breast and gastric cancer.
International journal of cancer. Journal international du cancer 1996;65(6):755-61.
-
1996: Luck H J; Thomssen C; duBois A; Lisboa B W; Untch M; Kuhnle H; Konecny G; Janicke F; Meerpohl H G; Lindner C; Hecker D; Diergarten K
Interim Analysis of a Phase II study of epirubicin and paclitaxel as first-line therapy in patients with metastatic breast cancer.
Seminars in oncology 1996;23(1 Suppl 1):33-6.
-
1995: Koechli O R; Schaer G N; Sevin B U; Perras J P; Schenk V; Rodriguez M; Untch M; Steren A; Haller U
In vitro chemosensitivity of paclitaxel and other chemotherapeutic agents in malignant gestational trophoblastic neoplasms.
Anti-cancer drugs 1995;6(1):94-100.
-
1995: Korell M; Untch M; Abels C; Dellian M; Kirschstein M; Baumgartner R; Beyer W; Goetz A E
[Use of photodynamic laser therapy in gynecology]
Gynäkologisch-geburtshilfliche Rundschau 1995;35(2):90-7.
-
1995: Untch M; Korell M; Kirschstein M; Hepp H
[The synergistic effect of delta-aminolevulinic acid and photodynamic laser therapy based on an in vitro model of the ATP tumor chemosensitivity test]
Gynäkologisch-geburtshilfliche Rundschau 1995;35(2):85-9.
-
1995: Kimmig R; Kapsner T; Spelsberg H; Untch M; Hepp H
DNA cell-cycle analysis of cervical cancer by flow cytometry using simultaneous cytokeratin labelling for identification of tumour cells.
Journal of cancer research and clinical oncology 1995;121(2):107-14.
-
1994: Koechli O R; Sevin B U; Perras J P; Angioli R; Untch M; Steren A; Ramachandran C; Averette H E
Comparative chemosensitivity profiles in three human breast cancer cell lines with the ATP-cell viability assay.
Oncology 1994;51(6):552-8.
-
1994: Kimmig R; Spelsberg H; Kapsner T; Untch M; Hepp H
Flow cytometric DNA analysis of breast cancer by two colour method using cytokeratin labeling for identification of tumour cells.
Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology 1994;7(3):205-15.
-
1994: Untch M; Sevin B U; Perras J P; Angioli R; Untch A; Hightower R D; Koechli O; Averette H E
Evaluation of paclitaxel (taxol), cisplatin, and the combination paclitaxel-cisplatin in ovarian cancer in vitro with the ATP cell viability assay.
Gynecologic oncology 1994;53(1):44-9.
-
1994: Harbeck N; Untch M; Pache L; Eiermann W
Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up.
British journal of cancer 1994;69(3):566-71.
-
1994: Untch M; Untch A; Sevin B U; Angioli R; Perras J P; Koechli O; Averette H E
Comparison of paclitaxel and docetaxel (Taxotere) in gynecologic and breast cancer cell lines with the ATP-cell viability assay.
Anti-cancer drugs 1994;5(1):24-30.
-
1994: Untch M; Sevin B U
Evaluation of new drugs and combinations in gynecologic tumors and cancer cell lines with the ATP-cell viability assay.
Contributions to gynecology and obstetrics 1994;19():145-55.
-
1993: Koechli O R; Sevin B U; Perras J P; Chou T C; Angioli R; Steren A; Untch M; Averette H E
Characteristics of the combination paclitaxel plus doxorubicin in breast cancer cell lines analyzed with the ATP-cell viability assay.
Breast cancer research and treatment 1993;28(1):21-7.
-
1993: Angioli R; Sevin B U; Perras J P; Untch M; Koechli O R; Nguyen H N; Steren A; Schwade J G; Villani C; Averette H E
In vitro potentiation of radiation cytotoxicity by recombinant interferons in cervical cancer cell lines.
Cancer 1993;71(11):3717-25.
-
1993: Angioli R; Untch M; Sevin B U; Steren A; Hightower R D; Perras J P; Nguyen H N; Koechli O R; Averette H E
Enhancement of progesterone receptor levels by interferons in AE-7 endometrial cancer cells.
Cancer 1993;71(9):2776-81.
-
1993: Hightower R D; Sevin B U; Perras J; Nguyen H; Angioli R; Untch M; Averette H
In vitro evaluation of the novel chemotherapeutic agents U-73,975, U-77,779, and U-80,244 in gynecologic cancer cell lines.
Cancer investigation 1993;11(3):276-82.
-
1993: Untch M; Nestle-Krämling C; Konecny G; Harbeck N; Funke I; Kimmig R; Hepp H
[Prognostic value of tumor cells in bone marrow in breast cancer]
Gynäkologisch-geburtshilfliche Rundschau 1993;33 Suppl 1():308-10.
-
1993: Kimmig R; Untch M; Pfeiffer D; Egner D; Strowitzki T; Hepp H
[Multiparametric flow cytometry determination of the EGF receptor and DNA cell cycle distribution in cervix cancer]
Gynäkologisch-geburtshilfliche Rundschau 1993;33 Suppl 1():283-4.
-
1993: Untch M; Sevin B U; Untch A; Konecny G; Nestle-Krämling C; Korell M; Hepp H
[Testing chemosensitivity of cancer cell lines and gynecologic tumors with the ATP assay]
Gynäkologisch-geburtshilfliche Rundschau 1993;33 Suppl 1():311-3.
-
1993: Konecny G; Nestle-Krämling C; Untch M
[Use of G-CSF in dose-intensified chemotherapy of breast cancer with FEC (500/75/500 mg/m2 KO) in the adjuvant and metastatic situation]
Gynäkologisch-geburtshilfliche Rundschau 1993;33 Suppl 1():301-2.
-
1992: Hightower R D; Sevin B U; Perras J P; Untch M; Angioli R; Ramos R; Averette H
Comparison of U-73,975 and cisplatin cytotoxicity in fresh cervical and ovarian carcinoma specimens with the ATP-chemosensitivity assay.
Gynecologic oncology 1992;47(2):186-90.
-
1992: Untch M; Sevin B U; Perras J P; Angioli R; Baibl A; Nguyen H N; Hightower R D; Averette H E
Chemosensitivity to the new anthracycline pirarubicin and other chemotherapeutic agents in primary and recurrent ovarian tumors in vitro.
Gynecologic oncology 1992;47(2):172-8.
-
1992: Nguyen H N; Sevin B U; Averette H; Perras J; Untch M; Ramos R; Donato D; Penalver M
Comparative evaluation of pirarubicin and adriamycin in gynecologic cancer cell lines.
Gynecologic oncology 1992;45(2):164-73.
-
1992: Angioli R; Sevin B U; Perras J P; Untch M; Hightower R D; Nguyen H N; Steren A; Villani C; Averette H E
Rationale of combining radiation and interferon for the treatment of cervical cancer.
Oncology 1992;49(6):445-9.
-
1990: Eiermann W; Harbeck N; Untch M
[Possibilities in immunocytochemistry exemplified by bone marrow aspiration cytology in patients with breast carcinoma]
Der Gynäkologe 1990;23(6):358-64.
Sign-in to see more
